JP2009504604A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009504604A5 JP2009504604A5 JP2008525548A JP2008525548A JP2009504604A5 JP 2009504604 A5 JP2009504604 A5 JP 2009504604A5 JP 2008525548 A JP2008525548 A JP 2008525548A JP 2008525548 A JP2008525548 A JP 2008525548A JP 2009504604 A5 JP2009504604 A5 JP 2009504604A5
- Authority
- JP
- Japan
- Prior art keywords
- ion
- use according
- treatment
- manufacture
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006673 asthma Diseases 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 7
- 230000002085 persistent effect Effects 0.000 claims 7
- -1 methanesulfonate ion Chemical class 0.000 claims 6
- 208000024891 symptom Diseases 0.000 claims 5
- 239000000556 agonist Substances 0.000 claims 4
- 238000012423 maintenance Methods 0.000 claims 3
- 206010006440 Bronchial obstruction Diseases 0.000 claims 2
- 150000001450 anions Chemical class 0.000 claims 2
- 239000003246 corticosteroid Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000002651 drug therapy Methods 0.000 claims 2
- 229940125369 inhaled corticosteroids Drugs 0.000 claims 2
- 238000009115 maintenance therapy Methods 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-L Oxalate Chemical compound [O-]C(=O)C([O-])=O MUBZPKHOEPUJKR-UHFFFAOYSA-L 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 229940006460 bromide ion Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims 1
- 229940006461 iodide ion Drugs 0.000 claims 1
- 230000002045 lasting effect Effects 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 229940085991 phosphate ion Drugs 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 229940110309 tiotropium Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05107266 | 2005-08-06 | ||
| PCT/EP2006/064958 WO2007017438A1 (en) | 2005-08-06 | 2006-08-02 | Use of tiotropium salts in the treatment of severe persistant asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009504604A JP2009504604A (ja) | 2009-02-05 |
| JP2009504604A5 true JP2009504604A5 (enExample) | 2009-09-17 |
Family
ID=35432680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525548A Pending JP2009504604A (ja) | 2005-08-06 | 2006-08-02 | 重症持続型喘息の治療におけるチオトロピウム塩の使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20070032516A1 (enExample) |
| EP (1) | EP1915158A1 (enExample) |
| JP (1) | JP2009504604A (enExample) |
| KR (1) | KR20080039974A (enExample) |
| CN (1) | CN101237872A (enExample) |
| AR (1) | AR055597A1 (enExample) |
| AU (1) | AU2006277968A1 (enExample) |
| BR (1) | BRPI0614394A2 (enExample) |
| CA (1) | CA2617717C (enExample) |
| IL (1) | IL189248A0 (enExample) |
| MX (1) | MX2008001506A (enExample) |
| NZ (1) | NZ566399A (enExample) |
| RU (1) | RU2422144C2 (enExample) |
| TW (1) | TWI409072B (enExample) |
| WO (1) | WO2007017438A1 (enExample) |
| ZA (1) | ZA200800186B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7250426B2 (en) | 2002-11-29 | 2007-07-31 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Tiotropium-containing pharmaceutical combination for inhalation |
| WO2007077162A1 (en) * | 2006-01-04 | 2007-07-12 | Boehringer Ingelheim International Gmbh | Use of tiotropium salts in the treatment of moderate persistent asthma |
| MX2012005711A (es) * | 2009-11-17 | 2012-10-05 | Cipla Ltd | Soluciones de inhalacion. |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| US5888396A (en) * | 1996-12-17 | 1999-03-30 | Perriello; Felix Anthony | Bioremediation of pollutants with butane-utilizing bacteria |
| US6156503A (en) * | 1997-03-03 | 2000-12-05 | The Regents Of The University Of California | Diagnosing asthma patients predisposed to adverse β-agonist reactions |
| GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
| GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
| CA2425539C (en) * | 2000-10-12 | 2007-04-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition |
| US6908928B2 (en) * | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| US6919325B2 (en) * | 2001-09-14 | 2005-07-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts |
| DE10216036A1 (de) * | 2002-04-11 | 2003-10-23 | Boehringer Ingelheim Pharma | Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz |
| WO2004014293A2 (en) * | 2002-06-12 | 2004-02-19 | Epigenesis Pharmaceuticals, Inc. | Combination of anti-muscarinic agents and non-glucocorticoid steroids |
| EP1531866A1 (en) * | 2002-08-29 | 2005-05-25 | Cipla Ltd. | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| SE0303571D0 (sv) * | 2003-12-03 | 2003-12-22 | Microdrug Ag | Medical product for moisture-sensitive medicaments |
| SE0303570L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
| AU2006244683A1 (en) * | 2005-05-10 | 2006-11-16 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
| AU2006248189A1 (en) * | 2005-05-20 | 2006-11-23 | Synergenz Bioscience Limited | Methods of analysis of polymorphisms and uses thereof |
| US20070167480A1 (en) * | 2005-12-19 | 2007-07-19 | Sicor Inc. | Pure and stable tiotropium bromide |
| WO2007077162A1 (en) | 2006-01-04 | 2007-07-12 | Boehringer Ingelheim International Gmbh | Use of tiotropium salts in the treatment of moderate persistent asthma |
-
2006
- 2006-08-02 CA CA2617717A patent/CA2617717C/en not_active Expired - Fee Related
- 2006-08-02 NZ NZ566399A patent/NZ566399A/en unknown
- 2006-08-02 JP JP2008525548A patent/JP2009504604A/ja active Pending
- 2006-08-02 MX MX2008001506A patent/MX2008001506A/es active IP Right Grant
- 2006-08-02 CN CNA2006800288506A patent/CN101237872A/zh active Pending
- 2006-08-02 RU RU2008108302/15A patent/RU2422144C2/ru active
- 2006-08-02 EP EP20060792647 patent/EP1915158A1/en not_active Ceased
- 2006-08-02 BR BRPI0614394-6A patent/BRPI0614394A2/pt not_active Application Discontinuation
- 2006-08-02 WO PCT/EP2006/064958 patent/WO2007017438A1/en not_active Ceased
- 2006-08-02 AU AU2006277968A patent/AU2006277968A1/en not_active Abandoned
- 2006-08-02 KR KR1020087005564A patent/KR20080039974A/ko not_active Ceased
- 2006-08-03 US US11/462,139 patent/US20070032516A1/en not_active Abandoned
- 2006-08-04 TW TW095128580A patent/TWI409072B/zh active
- 2006-08-04 AR ARP060103410A patent/AR055597A1/es unknown
-
2008
- 2008-01-08 ZA ZA200800186A patent/ZA200800186B/xx unknown
- 2008-02-04 IL IL189248A patent/IL189248A0/en unknown
-
2009
- 2009-02-19 US US12/388,879 patent/US20090163531A1/en not_active Abandoned
-
2012
- 2012-09-24 US US13/625,589 patent/US20130245059A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021152074A (ja) | ステロイドの抗痙攣活性 | |
| JP2011162556A5 (enExample) | ||
| JP2013542940A5 (enExample) | ||
| MX2013009525A (es) | Combinacion de glicopirrolato y un beta2-agonista. | |
| JP2011520911A5 (enExample) | ||
| CN101801378A (zh) | 治疗药物的新型组合 | |
| CN102724974A (zh) | 毒蕈碱受体拮抗剂和β-2肾上腺素受体激动剂的组合 | |
| JP2014516062A (ja) | ウメクリジニウム及びコルチコステロイドを含む組合せ | |
| JP2020023536A (ja) | Ｃｏｐｄの治療のためのフォルモテロール及びブデソニドの組み合わせ | |
| JP2007505139A5 (enExample) | ||
| JP2018537453A5 (enExample) | ||
| WO2006065722A2 (en) | Compositions and methods for pulmonary conditions | |
| US8877740B2 (en) | Compound composition for inhalation used for treating asthma | |
| WO2012168160A1 (en) | Dry powder inhaler compositions comprising umeclidinium | |
| WO2012110462A1 (en) | Liquid propellant-free formulation comprising an antimuscarinic drug | |
| JP2009504604A5 (enExample) | ||
| CN103476412A (zh) | 用于改善呼吸系统疾病患者睡眠质量的阿地铵 | |
| CN104955448A (zh) | 适用于吸入治疗的包含多组分结晶颗粒的药物组合物 | |
| RU2008108302A (ru) | Применение солей тиотропия для лечения тяжелых форм персистирующей астмы | |
| Lyseng-Williamson et al. | Tiotropium Respimat® Soft Mist™ inhaler: a guide to its use in chronic obstructive pulmonary disease (COPD) in the EU | |
| Kaplan | Effects of tiotropium combined with either salmeterol or salmeterol/fluticasone in moderate to severe COPD | |
| Choo | Combination therapy options in Stable COPD | |
| Chaplin et al. | Long‐acting bronchodilators: their properties and place in treatment | |
| Lyseng-Williamson et al. | Inhaled glycopyrronium bromide: a guide to its use in moderate to severe chronic obstructive pulmonary disease | |
| Syed et al. | Umeclidinium/vilanterol dry-powder inhaler in chronic obstructive pulmonary disease: a guide to its use in the EU |